The comparisons of the response rate to primary chemotherapy, progression-free survival time (PFS), response rate after first relapse and overall survival time (OS) were made between patients treated in 3 hospital categories according to annual enrolment rate. 273 of the patients had been treated ...
Capecitabine chemotherapy in combination with gemcitabine show median overall survival rate of 28 months. Pancreatic cancer patients given capecitabine chemotherapy in combination with gemcitabine achieved prolonged survival after surgery. Findings from the phase 3 trial were presented at the 2016 American Soc...
Meaning These results suggest that HIPEC after interval cytoreductive surgery may increase progression-free and overall survival in patients with ovarian cancer who receive neoadjuvant chemotherapy. Abstract Importance Ovarian cancer has the highest mortality rate among gynecologic malignant tumors. Data are ...
The research team administered the chemotherapy drug vincristine to obese and non-obese mice with leukemia. Researchers discovered that the mice that were switched to a low-fat diet had a dramatically improved survival rate of 92 percent, while the mice on the high-fat diet had a 17 percent s...
Hepatectomy and transplantation are the main surgical therapies for HCC patients, and radiotherapy or chemotherapy is often used as adjuvant treatment. Researches have evaluated the independent predictors of HCC, but evidence for factors predicting the e
Additionally, a correlation was observed between patients with chemotherapy and radiation (r = 0.304; p < 0.001). Treatment with surgery plus chemoradiation was superior to other regimens (HR = 0.600, 95%CI 0.438–0.822, p = 0.0015) (Figure S4), with a 5-year survival rate of 31.3% and...
Considering poor response rate of chemotherapy and low HER2 receptor positive rate of MpBC19,22, seeking novel therapeutic targets warrants attention. In our study, we found that 66.3% of MpBC were triple-negative subtype. Similar to prior studies4, the majority of metaplastic cases were triple ...
Takashima,Hiroshi Demachi.Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate[J... O Matsui,M Kadoya,J Yoshikawa… - 《Cancer Chemotherapy & Pharmacology》 被引量: 197发表: 1994年 Transcatheter Arterial Chemotherapy with ...
The concurrent administration of cisplatin and fluorouracil (CCRT) during radiotherapy after induction chemotherapy had better results than induction chemo... MS Yoon,WK Chung,SJ Ahn,... - Acta oto-laryngologica 被引量: 20发表: 2008年 Concomitant chemoradiotherapy (CT/RT) vs neoadjuvant chemotherapy...
The regimen has been tested in 25 patients with Hodgkin's disease refractory to primary chemotherapy (MOPP and ABVD) or relapsed within 12 months after first complete remission. The efficacy of the sequential regimen (72% complete response rate, 49% event-free survival and freedom from ...